Results 61 to 70 of about 104,116 (405)

Buprenorphine for Opioid Use Disorder in the Emergency Department: A Retrospective Chart Review

open access: yesWestern Journal of Emergency Medicine, 2020
Introduction: Emergency care providers routinely treat patients with acute presentations and sequelae of opioid use disorder. An emergency physician and pharmacist implemented a protocol using buprenorphine for the treatment of patients with opioid ...
Kathy T. LeSaint   +3 more
doaj   +1 more source

Administration of Tramadol or Buprenorphine via the drinking water for post-operative analgesia in a mouse-osteotomy model [PDF]

open access: yes, 2019
Adequate analgesia is essential whenever pain might occur in animal experiments. Unfortunately, the selection of suitable analgesics for mice in bone-linked models is limited. Here, we evaluated two analgesics - Tramadol [0.1 mg/ml (Tlow) vs.
Buttgereit, Frank   +7 more
core   +1 more source

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail

open access: yesJAMA Network Open, 2021
Key Points Question Is extended-release buprenorphine an acceptable and helpful jail-to-community treatment option among adults already receiving daily sublingual buprenorphine for opioid use disorders? Findings In this pilot proof-of-concept comparative
Joshua D. Lee   +13 more
semanticscholar   +1 more source

Perioperative Buprenorphine Management and Postoperative Pain Outcomes: A Retrospective Study with Evidence-Based Recommendations

open access: yesInternational Journal of Translational Medicine
The prevalence of patients on buprenorphine therapy presenting for elective surgery has increased. Buprenorphine is a widely used medication for the management of patients with chronic pain.
Amruta Desai   +2 more
doaj   +1 more source

Utilization of Telehealth Solutions for Patients with Opioid Use Disorder Using Buprenorphine: A Scoping Review.

open access: yesTelemedicine journal and e-health, 2021
Background: A scoping review was conducted to examine the breadth of evidence related to telehealth innovations being utilized in the treatment of opioid use disorder (OUD) with buprenorphine and its effect on patient outcomes and health care delivery ...
Aileen G Guillen   +3 more
semanticscholar   +1 more source

Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions

open access: yesWestern Journal of Emergency Medicine, 2022
Emergency departments (ED) are increasingly providing buprenorphine to persons with opioid use disorder. Buprenorphine programs in the ED have strong support from public health leaders and emergency medicine specialty societies and have proven to be ...
Timothy D. Kelly   +4 more
doaj   +1 more source

Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant. [PDF]

open access: yes, 2016
Opioid use in pregnancy has increased dramatically over the past decade. Since prenatal opioid use is associated with numerous obstetrical and neonatal complications, this now has become a major public health problem.
Davis, Jonathan M.   +2 more
core   +2 more sources

Defining Low-threshold Buprenorphine Treatment.

open access: yesJournal of addiction medicine, 2020
: Buprenorphine treatment for opioid use disorder is safe and effective, but only a fraction of Americans who need treatment receive it. One reason for this is that many buprenorphine treatment programs have rigid requirements for entry and continuation,
Andrea Jakubowski, A. Fox
semanticscholar   +1 more source

Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis

open access: yesJournal of addiction medicine, 2021
Objectives: Patients with opioid use disorder (OUD) can initiate buprenorphine without requiring a withdrawal period through a low-dose (sometimes referred to as “micro-induction”) approach.
Dana Button   +5 more
semanticscholar   +1 more source

Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach

open access: yesAddiction Science & Clinical Practice, 2020
Background The requirement for moderate withdrawal prior to initiation can be a barrier to buprenorphine/naloxone induction. Case presentation We aimed to use a microdosing regimen to initiate regular dosing of buprenorphine/naloxone in a high-risk ...
Jennifer Rozylo   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy